argus

Neuland Laboratories Limited.

NSE: NEULANDLABINE794A0101029,452 Cr

Timeline

Time (IST)TypeMEventSrc
12 May, 04:18 pmNeuland Laboratories Ltd - 524558 - Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2025-26bse
12 May, 04:11 pmBoard Meeting Outcome for Audited Financial Results And Recommendation Of Final Dividend For Financial Year 2025-26nse
29 Apr, 10:52 amQ4FY26 Earnings Call Intimationnse
21 Apr, 01:43 pmNewspaper Publication of Notice for transferring unclaimed dividend and underlying equity shares to IEPFnse
20 Apr, 08:21 pmNeuland Laboratories Ltd - 524558 - Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026, And; To Recommend Final Dividend, If Any, For The Financial Year Ended March 31, 2026bse
09 Apr, 04:29 pmNeuland Laboratories Limited has informed the Exchange regarding 'Compliance Certificate Pursuant To SEBI Exemption Order Dated January 3, 2025 For The Financial Year Ended March 31, 2026'.nse
07 Apr, 12:58 pmNeuland Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
01 Apr, 01:43 pmNeuland Laboratories Limited has informed the Exchange regarding a press release dated April 01, 2026, titled "Press Release".nse
01 Apr, 01:43 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
27 Mar, 05:17 pmNeuland Laboratories Ltd - 524558 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011bse
19 Mar, 12:20 pmNeuland Laboratories Ltd - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificatebse
12 Mar, 03:16 pmNeuland Laboratories Ltd - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificatebse
03 Mar, 11:43 amNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Demisebse
03 Mar, 11:43 amNeuland Laboratories Limited has informed the Exchange regarding Demise of Dr. Christopher M Cimarusti, Non- Executive Director of the company on February 28, 2026.nse
13 Feb, 11:20 amNeuland Laboratories Limited has informed the Exchange about Transcriptnse
13 Feb, 11:20 amNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
11 Feb, 04:24 pmNeuland Laboratories Limited has informed the Exchange regarding 'Re-Lodgement of Transfer Request of Physical Shares'.nse
09 Feb, 07:44 pmNeuland Laboratories Limited has informed the Exchange about Link of Recordingnse
09 Feb, 07:44 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
09 Feb, 05:49 pmNeuland Laboratories Limited has informed the Exchange regarding a revised press release dated February 09, 2026, titled "Revised Press Release - Rectification of typo error".nse
09 Feb, 05:48 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)bse
09 Feb, 04:29 pmNeuland Laboratories Limited has informed the Exchange about Investor Presentationnse
09 Feb, 04:29 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
09 Feb, 04:20 pmNeuland Laboratories Limited has informed the Exchange regarding a press release dated February 09, 2026, titled "Press Release on the Financial Results of the Company for the quarter and nine months ended December 31, 2025".nse
09 Feb, 04:20 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
09 Feb, 04:14 pmNeuland Laboratories Ltd - 524558 - Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025bse
09 Feb, 04:09 pmUnaudited Financial Results of the Company for the quarter and nine months ended December 31, 2025nse
30 Jan, 03:57 pmNeuland Laboratories Limited has informed the Exchange regarding 'Intimation regarding conversion of Statutory Auditor s Firm to a Limited Liability Partnership (LLP)'.nse
21 Jan, 03:46 pmNeuland Laboratories Ltd - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2025bse
02 Jan, 05:27 pmNeuland Laboratories Limited has informed the Exchange regarding 'Re-Lodgement of Transfer Request of Physical Shares'.nse
15 Dec, 09:01 amIntimation about Schedule of Analyst / Institutional Investor Meeting on December 18, 2025nse
09 Dec, 05:44 pmNeuland Laboratories Limited has informed the Exchange about Intimation of cancellation of Analyst / Institutional Investor Meeting scheduled to be held on December 10, 2025nse
08 Dec, 12:50 pmNeuland Laboratories Limited has informed the Exchange regarding 'Re-Lodgement Of Transfer Request Of Physical Shares'.nse
06 Dec, 11:07 amIntimation about Schedule of Analyst / Institutional Investor Meeting on December 10, 2025nse
28 Nov, 05:42 pmIntimation about Schedule of Analyst / Institutional Investor Meeting on December 4 & 5, 2025nse
28 Nov, 05:27 pmDisclosure Under Regulation 30 of SEBI Listing Regulationnse
21 Nov, 12:03 pmNeuland Laboratories Limited has informed the Exchange regarding 'Re-Lodgement Of Transfer Request Of Physical Shares'.nse
12 Nov, 01:57 pmNeuland Laboratories Limited has informed the Exchange about Transcriptnse
12 Nov, 01:57 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
07 Nov, 08:33 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
07 Nov, 08:33 pmAudio Recording of the Earnings call conducted on November 7, 2025nse
07 Nov, 04:34 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
07 Nov, 04:34 pmNeuland Laboratories Limited has informed the Exchange about Investor Presentationnse
07 Nov, 04:28 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
07 Nov, 04:27 pmNeuland Laboratories Limited has informed the Exchange regarding a press release dated November 07, 2025, titled "Press Release on the Financial Results of the Company for the quarter and half year ended September 30, 2025".nse
07 Nov, 04:22 pmNeuland Laboratories Ltd - 524558 - Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025bse
07 Nov, 04:16 pmUnaudited Financial Results of the Company for the quarter and half year ended September 30, 2025nse
24 Oct, 05:09 pmNeuland Laboratories Ltd - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025bse
17 Oct, 03:45 pmNeuland Laboratories Limited has informed the Exchange regarding 'Re-Lodgement Of Transfer Request Of Physical Shares'.nse
23 Sept, 06:47 pmNeuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Change in Managementbse